Veritas enters into Commercial Development Agreement with FZMB to commercialize the ABICAP technologies.The company fzmb GmbH was founded in 1994. They are active in research and realization of innovative services since 1995 and on the Canadian Market since 2001. fzmb GmbH employs 93 people from different branches in interdisciplinary research teams of Physicists, engineers, doctors, chemists, biologists, technicians and nurses and veterinary clinic.
The major R&D activities of fzmb GmbH include the development of new methods for diagnostics and treatment of arthritis (biomarker, cartilage repair, x-ray analysis) and of innovative methods (immunoassays) for the detection of food contaminants and point of care test systems for veterinary and bio safety applications.
Under this Agreement, Veritas will partner with FZMB to commercial develop the novel ABICAP technoloiges and products in North America as well as in the Far East. Read more about fzmb GmbH. Read more about the ABICAP technologies and products currently available for sale.